Hello, welcome to Tosun!
会员中心

Product introduction:

First intravenous and intramuscular specific cyclooxygenase-2 (COX-2) inhibitor can be used for the short-term treatment of postoperative pain, as well as for the treatment of moderate or severe postoperative acute pain in the world.

市场价:

  • Product information
  • 产品描述
  • 参数配置


1、 Product introduction

Chinese Name

English Name

Declaration Type

Department

Reportable Dosage Form

Declaration Progress

Strength

CAS
帕瑞昔布钠PARECOXIB SODIUM5+4Analgesics Freeze dried powder 

Preparing for declaration

20mg、40mg198470-85-8

Indication

    Analgesics 


Reportable Dosage Form &Strength
       Freeze dried powder :20mg、40mg


Declaration Progress
         Preparing for declaration



2、Domestic Declaration


Declaration Type

Reportable Dosage Form

Number of Declared Preparations

Number of Existing Preparation Enterprises

5+4冻干粉

22 domestic declaration enterprises

1 import enterprise.





 Brinzolamide 布林佐胺 CAS号:138890-62-7

Guangzhou Tosun Pharmaceutical Ltd

FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663

Tel: +86-20-66392521; Fax: +86-20-66392525

First intravenous and intramuscular specific cyclooxygenase-2 (COX-2) inhibitor can be used for the short-term treatment of postoperative pain, as well as for the treatment of moderate or severe postoperative acute pain in the world.

The world's first intravenous drug and intramuscular injection 

热门关键词: 进口原料药代理 印度进口原料药 原料药关联审评 进口药品注册代理 国内参比制剂 美国参比制剂 原料药注册服务 原料药联合申报 原料药供应商
Copyright ©2020 Guangzhou Tosun Pharmaceutical Ltd 粤ICP备16102594号-2
MapsXML Maps  Maps
Phone

(86)18922121079

(86)18026299762

TOP